CompanyDeals

Sihuan’s Hui Sheng Bio Completes Series A+ Financing for Diabetes Pipeline

CompanyDrug

HutchMed Completes Enrollment for Phase III ESLIM-01 Study of Sovleplenib in ITP

CompanyDrug

RemeGen’s RC48 Gains NMPA Approval for Phase II Study in Bladder Cancer

CompanyDeals

Apeloa and Simcere Partner for CDMO Services and R&D Collaboration

CompanyDeals

Sino Biopharmaceutical’s CTTQ Partners with ProteLight for Antibacterial Peptide PL-5

CompanyDeals

Inscinstech Raises RMB 150 Million in Series A+, B, and B+ Rounds

Company

Everest Medicines Outlines Strategic Plans for Expansion and Growth

Company

Zai Lab Appoints Dr. Rafael Amado as President of Cancer R&D

CompanyDrug

Jiangxi Jemincare Gains FDA Approval for Clinical Trial of JYB1907 in Solid Tumors

CompanyDrug

Mabwell Receives NMPA Approval for Clinical Trial of 9MW3011 in Rare Diseases

CompanyDrug

Staidson’s Anti-C5a Monoclonal Antibody STSA-1002 Accepted for NMPA Review

CompanyDeals

Guangdong Raynovent Biotech Secures RMB 370 Million in Series C Financing